TRP channels in lower urinary tract dysfunction

British Journal of Pharmacology

Volumn 171, Issue 10, 2014, Pages 2537-2551

  Franken, J ^a   Uvin, P ^a   De Ridder, D ^a   Voets, T ^b  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

Author keywords

Lower urinary tract; TRP channel; Urology

Indexed keywords

TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 4; AGENTS AFFECTING WATER, MOLECULE OR ION TRANSPORT; URINARY TRACT AGENT;

BLADDER IRRITATION; COOLING; CYSTALGIA; DISEASE SEVERITY; HEAT; HUMAN; IDIOPATHIC DETRUSOR OVERACTIVITY; INTERSTITIAL CYSTITIS; LOWER URINARY TRACT SYMPTOM; MICTURITION REFLEX; NEUROGENIC DETRUSOR OVERACTIVITY; NONHUMAN; OVERACTIVE BLADDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; QUALITY OF LIFE; REVIEW; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; ANIMAL; BLADDER; DRUG DESIGN; DRUG EFFECTS; INNERVATION; LOWER URINARY TRACT SYMPTOMS; METABOLISM; MOLECULARLY TARGETED THERAPY; PATHOPHYSIOLOGY; SENSORY NERVE CELL; URINARY BLADDER DISEASES;

ANIMALS; DRUG DESIGN; HUMANS; LOWER URINARY TRACT SYMPTOMS; MEMBRANE TRANSPORT MODULATORS; MOLECULAR TARGETED THERAPY; SENSORY RECEPTOR CELLS; SIGNAL TRANSDUCTION; TRANSIENT RECEPTOR POTENTIAL CHANNELS; URINARY BLADDER; URINARY BLADDER DISEASES; UROLOGICAL AGENTS;

EID: 84900835778     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12502     Document Type: Review

References (147)

1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. (2003). The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61: 37-49.
2. Akopian AN, Ruparel NB, Patwardhan A, Hargreaves KM, (2008). Cannabinoids desensitize capsaicin and mustard oil responses in sensory neurons via TRPA1 activation. J Neurosci 28: 1064-1075.
3. Andersson K-E, (2011). Antimuscarinic mechanisms and the overactive detrusor: an update. J Urol 59: 377-386.
4. Andrade EL, Ferreira J, André E, Calixto JB, (2006). Contractile mechanisms coupled to TRPA1 receptor activation in rat urinary bladder. Biochem Pharmacol 72: 104-114.
5. Andrade EL, Forner S, Bento AF, Leite DFP, Dias MA, Leal PC, et al. (2011). TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury. Am J Physiol Renal Physiol 300: F1223-F1234.
6. Apostolidis A, Brady CM, Yiangou Y, Davis J, Fowler CJ, Anand P, (2005). Capsaicin receptor TRPV1 in urothelium of neurogenic human bladders and effect of intravesical resiniferatoxin. Urology 65: 400-405.
7. Atalik KE, Okudan N, Gokbel H, Kalkan S, Cuce G, (2010). Diabetes mellitus- and cooling-induced bladder contraction: an in vitro study. J Smooth Muscle Res 46: 175-183.
8. Athanasiou A, Smith PA, Vakilpour S, Kumaran NM, Turner AE, Bagiokou D, et al. (2007). Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 354: 50-55.
9. Avelino A, Cruz C, Nagy I, Cruz F, (2002). Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109: 787-798.
10. Barbanti GG, Maggi CAC, Beneforti PP, Baroldi PP, Turini DD, (1993). Relief of pain following intravesical capsaicin in patients with hypersensitive disorders of the lower urinary tract. Br J Urol 71: 686-691.
11. Bautista DM, Jordt S-E, Nikai T, Tsuruda PR, Read AJ, Poblete J, et al. (2006). TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents. Cell 124: 1269-1282.
12. Birder L, Andersson K-E, (2013). Urothelial signaling. Physiol Rev 93: 653-680.
13. Birder LA, Kanai AJ, de Groat WC, Kiss S, Nealen ML, Burke NE, et al. (2001). Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 98: 13396-13401.
14. Birder LA, Kullmann FA, Lee H, Barrick S, de Groat W, Kanai A, et al. (2007). Activation of urothelial transient receptor potential vanilloid 4 by 4alpha-phorbol 12,13-didecanoate contributes to altered bladder reflexes in the rat. J Pharmacol Exp Ther 323: 227-235.
15. Birder LA, Wolf-Johnston AS, Sun Y, Chai TC, (2013). Alteration in TRPV1 and Muscarinic (M3) receptor expression and function in idiopathic overactive bladder urothelial cells. Acta Physiol (Oxf) 207: 123-129.
16. Bjorling DE, Wang Z-Y, Bushman W, (2011). Models of inflammation of the lower urinary tract. Neurourol Urodyn 30: 673-682.
17. Bley K, (2012). Effects of topical capsaicin on cutaneous innervation: implications for pain management. Open Pain J 6: 81-94.
18. Bonnington JK, McNaughton PA, (2003). Signalling pathways involved in the sensitisation of mouse nociceptive neurones by nerve growth factor. J Physiol (Lond) 551: 433-446.
19. Bors EH, Blinn KA, (1957). Spinal reflex activity from the vesical mucosa in paraplegic patients. AMA Arch Neurol Psychiatry 78: 339-354.
20. Brady CM, Apostolidis AN, Harper M, Yiangou Y, Beckett A, Jacques TS, et al. (2004). Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment. BJU Int 93: 770-776.
21. Brederson J-D, Kym PR, Szallasi A, (2013). Targeting TRP channels for pain relief. Eur J Pharmacol 716: 61-76.
22. Burns AS, Rivas DA, Ditunno JF, (2001). The management of neurogenic bladder and sexual dysfunction after spinal cord injury. Spine 26: S129-S136.
23. Cacabelos R, Rodríguez B, Carrera C, Caamaño J, Beyer K, Lao JI, et al. (1996). APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol 18: 693-706.
24. Campos-Sousa RN, Quagliato E, da Silva BB, de Carvalho RM, Ribeiro SC, de Carvalho DFM, (2003). Urinary symptoms in Parkinson's disease: prevalence and associated factors. Arq Neuropsiquiatr 61: 359-363.
25. Capasso R, Aviello G, Romano B, Borrelli F, De Petrocellis L, Di Marzo V, et al. (2012). Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects. Br J Pharmacol 165: 1966-1977.
26. Cavanaugh DJ, Chesler AT, Jackson AC, Sigal YM, Yamanaka H, Grant R, et al. (2011). Trpv1 reporter mice reveal highly restricted brain distribution and functional expression in arteriolar smooth muscle cells. J Neurosci 31: 5067-5077.
27. Chandiramani VA, Peterson T, Duthie GS, Fowler CJ, (1996). Urodynamic changes during therapeutic intravesical instillations of capsaicin. Br J Urol 77: 792-797.
28. Charrua A, Cruz CD, Cruz F, Avelino A, (2007). Transient receptor potential vanilloid subfamily 1 is essential for the generation of noxious bladder input and bladder overactivity in cystitis. J Urol 177: 1537-1541.
29. Charrua A, Cruz CD, Narayanan S, Gharat L, Gullapalli S, Cruz F, et al. (2009). GRC-6211, a new oral specific TRPV1 antagonist, decreases bladder overactivity and noxious bladder input in cystitis animal models. J Urol 181: 379-386.
30. Chen Z, Ishizuka O, Imamura T, Aizawa N, Kurizaki Y, Igawa Y, et al. (2010). Stimulation of skin menthol receptors stimulates detrusor activity in conscious rats. Neurourol Urodyn 29: 506-511.
31. Cho KJ, Park EY, Kim HS, Koh JS, Kim JC, (2013). Expression of transient receptor potential vanilloid 4 and effects of ruthenium red on detrusor overactivity associated with bladder outlet obstruction in rats. World J Urol (Epub ahead of print).
32. Cockayne DA, Hamilton SG, Zhu QM, Dunn PM, Zhong Y, Novakovic S, et al. (2000). Urinary bladder hyporeflexia and reduced pain-related behaviour in P2X3-deficient mice. Nature 407: 1011-1015.
33. Colburn RW, Lubin ML, Stone DJ Jr, Wang Y, Lawrence D, D'Andrea MR, et al. (2007). Attenuated cold sensitivity in TRPM8 null mice. Neuron 54: 379-386.
34. Combrisson H, Allix S, Robain G, (2007). Influence of temperature on urethra to bladder micturition reflex in the awake ewe. Neurourol Urodyn 26: 290-295.
35. Cruz F, (1998). Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia or bladder hypersensitivity disorders. Int Urogynecol J Pelvic Floor Dysfunct 9: 214-220.
36. Cruz FF, Guimarães MM, Silva CC, Rio MEM, Coimbra AA, Reis MM, (1997). Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction. J Urol 157: 585-589.
37. Dang K, Bielefeldt K, Gebhart GF, (2013). Cyclophosphamide-induced cystitis reduces ASIC channel but enhances TRPV1 receptor function in rat bladder sensory neurons. J Neurophysiol 110: 408-417.
38. De Ridder D, Chandiramani V, Dasgupta P, Van Poppel H, Baert L, Fowler CJ, (1997). Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term followup. J Urol 158: 2087-2092.
39. De Ridder D, Ost D, Van der Aa F, Stagnaro M, Beneton C, Gross-Paju K, et al. (2005). Conservative bladder management in advanced multiple sclerosis. Mult Scler 11: 694-699.
40. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, et al. (2002). Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA Study. J Am Geriatr Soc 50: 41-48.
41. Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, et al. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374: 1677-1686.
42. Du S, Araki I, Yoshiyama M, Nomura T, Takeda M, (2007). Transient receptor potential channel A1 involved in sensory transduction of rat urinary bladder through C-fiber pathway. Urology 70: 826-831.
43. Du S, Araki I, Kobayashi H, Zakoji H, Sawada N, Takeda M, (2008). Differential expression profile of cold (TRPA1) and cool (TRPM8) receptors in human urogenital organs. Urology 72: 450-455.
44. Dua T, Rompani P, World Health Organization (2008). Atlas (World Health Organization).
45. Ellenberg M, (1980). Development of urinary bladder dysfunction in diabetes mellitus. Ann Intern Med 92: 321-323.
46. Everaerts W, Gevaert T, Nilius B, De Ridder D, (2008). On the origin of bladder sensing: Tr(i)ps in urology. Neurourol Urodyn 27: 264-273.
47. Everaerts W, Sepúlveda MR, Gevaert T, Roskams T, Nilius B, de Ridder D, (2009). Where is TRPV1 expressed in the bladder, do we see the real channel? Naunyn Schmiedebergs Arch Pharmacol 379: 421-425.
48. Everaerts W, Vriens J, Owsianik G, Appendino G, Voets T, De Ridder D, et al. (2010a). Functional characterization of transient receptor potential channels in mouse urothelial cells. Am J Physiol Renal Physiol 298: F692-F701.
49. Everaerts W, Zhen X, Ghosh D, Vriens J, Gevaert T, Gilbert JP, et al. (2010b). Inhibition of the cation channel TRPV4 improves bladder function in mice and rats with cyclophosphamide-induced cystitis. Proc Natl Acad Sci USA 107: 19084-19089.
50. Everaerts W, Gees M, Alpizar YA, Farre R, Leten C, Apetrei A, et al. (2011). The capsaicin receptor TRPV1 is a crucial mediator of the noxious effects of mustard oil. Curr Biol 21: 316-321.
51. Fall M, Lindström S, Maziéres L, (1990). A bladder-to-bladder cooling reflex in the cat. J Physiol (Lond) 427: 281-300.
52. Fernandes ES, Fernandes MA, Keeble JE, (2012). The functions of TRPA1 and TRPV1: moving away from sensory nerves. Br J Pharmacol 166: 510-521.
53. Fowler CJ, (2002). Bladder afferents and their role in the overactive bladder. Urology 59: 37-42.
54. Fowler CJC, Jewkes DD, McDonald WIW, Lynn BB, de Groat WCW, (1992). Intravesical capsaicin for neurogenic bladder dysfunction. Lancet 339: 1239-1239.
55. Freeman CR, Farmer JP, (1998). Pediatric brain stem gliomas: a review. Int J Radiat Oncol Biol Phys 40: 265-271.
56. Geirsson GG, Fall MM, Sullivan LL, (1995). Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hyperreflexia. J Urol 154: 1825-1829.
57. Geppetti P, Nassini R, Materazzi S, Benemei S, (2008). The concept of neurogenic inflammation. BJU Int 101 (Suppl. 3): 2-6.
58. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, et al. (2007). Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453-3462.
59. Ghei M, Malone-Lee J, (2005). Using the circumstances of symptom experience to assess the severity of urgency in the overactive bladder. J Urol 174: 972-976.
60. Giannantoni A, Scivoletto G, Di Stasi SM, Grasso MG, Finazzi Agrò E, Collura G, et al. (1999). Lower urinary tract dysfunction and disability status in patients with multiple sclerosis. Arch Phys Med Rehabil 80: 437-441.
61. Giannantoni A, Mearini E, Di Stasi SM, Costantini E, Zucchi A, Mearini L, et al. (2004). New therapeutic options for refractory neurogenic detrusor overactivity. Minerva Urol Nefrol 56: 79-87.
62. Giannantoni A, Conte A, Farfariello V, Proietti S, Vianello A, Nardicchi V, et al. (2013). Onabotulinumtoxin-A intradetrusorial injections modulate bladder expression of NGF, TrkA, p75 and TRPV1 in patients with detrusor overactivity. Pharmacol Res 68: 118-124.
63. Gratzke C, Streng T, Waldkirch E, Sigl K, Stief C, Andersson K-E, et al. (2009). Transient receptor potential A1 (TRPA1) activity in the human urethra-evidence for a functional role for TRPA1 in the outflow region. Eur Urol 55: 696-704.
64. de Groat WC, (1997). A neurologic basis for the overactive bladder. Urology 50: 36-52; discussion 53-56.
65. Ha U-S, Park EY, Kim JC, (2011). Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity. Urology 78: 721.e1-721.e6.
66. Ham BK, Kim JH, Oh MM, Lee JG, Bae JH, (2012). Effects of combination treatment of intravesical resiniferatoxin instillation and hydrodistention in patients with refractory painful bladder syndrome/interstitial cystitis: a pilot study. Int Neurourol J 16: 41-46.
67. Hayashi T, Kondo T, Ishimatsu M, Takeya M, Igata S, Nakamura K-I, et al. (2011). Function and expression pattern of TRPM8 in bladder afferent neurons associated with bladder outlet obstruction in rats. Auton Neurosci 164: 27-33.
68. Hindmarsh JR, Gosling PT, Deane AM, (1983). Bladder instability. Is the primary defect in the urethra? Br J Urol 55: 648-651.
69. Homma Y, Nomiya A, Tagaya M, Oyama T, Takagaki K, Nishimatsu H, et al. (2013). Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J Urol 190: 1925-1931.
70. Imamura T, Ishizuka O, Aizawa N, Zhong C, Ogawa T, Nakayama T, et al. (2008). Cold environmental stress induces detrusor overactivity via resiniferatoxin-sensitive nerves in conscious rats. Neurourol Urodyn 27: 348-352.
71. Jasmin L, Janni G, Manz HJ, Rabkin SD, (1998). Activation of CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Neurosci 18: 10016-10029.
72. Jiang C, Yang H, Fu X, Qu S, Lindström S, (2008). Bladder cooling reflex and external urethral sphincter activity in the anesthetized and awake guinea pig. Pflugers Arch 457: 61-66.
73. Jiang CH, Maziéres L, Lindström S, (2002). Cold- and menthol-sensitive C afferents of cat urinary bladder. J Physiol (Lond) 543: 211-220.
74. Jordt SE, Ehrlich BE, (2007). TRP channels in disease. Subcell Biochem 45: 253-271.
75. Jun JH, Kang HJ, Jin MH, Lee HY, Im YJ, Jung HJ, et al. (2012). Function of the cold receptor (TRPM8) associated with voiding dysfunction in bladder outlet obstruction in rats. Int Neurourol J 16: 69-76.
76. Karashima Y, Damann N, Prenen J, Talavera K, Segal A, Voets T, et al. (2007). Bimodal action of menthol on the transient receptor potential channel TRPA1. J Neurosci 27: 9874-9884.
77. Katusic SK, Colligan RC, Beard CM, O'Fallon WM, Bergstralh EJ, Jacobsen SJ, et al. (1996). Mental retardation in a birth cohort, 1976-1980, Rochester, Minnesota. Am J Ment Retard 100: 335-344.
78. Kawaguchi Y, Kanamori M, Ishihara H, Ohmori K, Fujiuchi Y, Matsui H, et al. (2001). Clinical symptoms and surgical outcome in lumbar spinal stenosis patients with neuropathic bladder. J Spinal Disord 14: 404-410.
79. Kim JH, Rivas DA, Shenot PJ, Green B, Kennelly M, Erickson JR, et al. (2003). Intravesical resiniferatoxin for refractory detrusor hyperreflexia: a multicenter, blinded, randomized, placebo-controlled trial. J Spinal Cord Med 26: 358-363.
80. Klein AH, Sawyer CM, Carstens MI, Tsagareli MG, Tsiklauri N, Carstens E, (2010). Topical application of L-menthol induces heat analgesia, mechanical allodynia, and a biphasic effect on cold sensitivity in rats. Behav Brain Res 212: 179-186.
81. Knowlton WM, McKemy DD, (2011). TRPM8: from cold to cancer, peppermint to pain. Curr Pharm Biotechnol 12: 68-77.
82. Kullmann FA, Shah MA, Birder LA, de Groat WC, (2009). Functional TRP and ASIC-like channels in cultured urothelial cells from the rat. Am J Physiol Renal Physiol 296: F892-F901.
83. Kuo H-C, (2003a). Effectiveness of intravesical resiniferatoxin for anticholinergic treatment refractory detrusor overactivity due to nonspinal cord lesions. J Urol 170: 835-839.
84. Kuo H-C, (2003b). Effectiveness of intravesical resiniferatoxin in treating detrusor hyper-reflexia and external sphincter dyssynergia in patients with chronic spinal cord lesions. BJU Int 92: 597-601.
85. Kuo H-C, (2005). Multiple intravesical instillation of low-dose resiniferatoxin is effective in the treatment of detrusor overactivity refractory to anticholinergics. BJU Int 95: 1023-1027.
86. Kuo H-C, Liu H-T, Yang W-C, (2006). Therapeutic effect of multiple resiniferatoxin intravesical instillations in patients with refractory detrusor overactivity: a randomized, double-blind, placebo controlled study. J Urol 176: 641-645.
87. Landouré G, Zdebik AA, Martinez TL, Burnett BG, Stanescu HC, Inada H, et al. (2010). Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet 42: 170-174.
88. Lazzeri M, Beneforti P, Spinelli M, Zanollo A, Barbagli G, Turini D, (2000). Intravesical resiniferatoxin for the treatment of hypersensitive disorder: a randomized placebo controlled study. J Urol 164: 676-679.
89. Lazzeri M, Vannucchi MG, Zardo C, Spinelli M, Beneforti P, Turini D, et al. (2004). Immunohistochemical evidence of vanilloid receptor 1 in normal human urinary bladder. Eur Urol 46: 792-798.
90. Li M, Sun Y, Simard JM, Chai TC, (2011). Increased transient receptor potential vanilloid type 1 (TRPV1) signaling in idiopathic overactive bladder urothelial cells. Neurourol Urodyn 30: 606-611.
91. Liedtke WB, Heller S, Cui K, Yuan X-B, (2007a). TRP Channels and Axon Pathfinding. CRC Press: Boca Raton, FL.
92. Liedtke WB, Heller S, Plant TD, Strotmann R, (2007b). TRPV4: A Multifunctional Nonselective Cation Channel with Complex Regulation. CRC Press: Boca Raton, FL.
93. Lindström S, Mazières L, Jiang C-H, (2004). Inhibition of the bladder cooling reflex in the awake state: an experimental study in the cat. J Urol 172: 2051-2053.
94. Liu H-T, Kuo H-C, (2007). Increased expression of transient receptor potential vanilloid subfamily 1 in the bladder predicts the response to intravesical instillations of resiniferatoxin in patients with refractory idiopathic detrusor overactivity. BJU Int 100: 1086-1090.
95. Liu L, Mansfield KJ, Kristiana I, Vaux KJ, Millard RJ, Burcher E, (2007). The molecular basis of urgency: regional difference of vanilloid receptor expression in the human urinary bladder. Neurourol Urodyn 26: 433-438; discussion 439; discussion 451-453.
96. McNamara CR, Mandel-Brehm J, Bautista DM, Siemens J, Deranian KL, Zhao M, et al. (2007). TRPA1 mediates formalin-induced pain. Proc Natl Acad Sci USA 104: 13525-13530.
97. Madersbacher H, (1990). The various types of neurogenic bladder dysfunction: an update of current therapeutic concepts. Paraplegia 28: 217-229.
98. Maggi CA, (1990). The dual function of capsaicin-sensitive sensory nerves in the bladder and urethra. Ciba Found Symp 151: 77-83; discussion 83-90.
99. Maggi CA, Santicioli P, Giuliani S, Furio M, Meli A, (1986). The capsaicin-sensitive innervation of the rat urinary bladder: further studies on mechanisms regulating micturition threshold. J Urol 136: 696-700.
100. Maggi CA, Barbanti G, Santicioli P, Beneforti P, Misuri D, Meli A, et al. (1989). Cystometric evidence that capsaicin-sensitive nerves modulate the afferent branch of micturition reflex in humans. J Urol 142: 150-154.
101. Maggi CA, Patacchini R, Tramontana M, Amann R, Giuliani S, Santicioli P, (1990). Similarities and differences in the action of resiniferatoxin and capsaicin on central and peripheral endings of primary sensory neurons. Neuroscience 37: 531-539.
102. Matsunami M, Miki T, Nishiura K, Hayashi Y, Okawa Y, Nishikawa H, et al. (2012). Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice. Br J Pharmacol 167: 917-928.
103. Matsuoka PK, Haddad JM, Pacetta AM, Baracat EC, (2012). Intravesical treatment of painful bladder syndrome: a systematic review and meta-Analysis. Int Urogynecol J 23: 1147-1153.
104. Maziéres L, Jiang CH, Lindström S, (2006). Recurrent inhibition of the bladder C fibre reflex in the cat and its response to naloxone. J Physiol (Lond) 575: 603-615.
105. Mitchell SJ, Woodthorpe J, (1981). Young mentally handicapped adults in three London boroughs: prevalence and degree of disability. J Epidemiol Community Health 35: 59-64.
106. Mochizuki T, Sokabe T, Araki I, Fujishita K, Shibasaki K, Uchida K, et al. (2009). The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 284: 21257-21264.
107. Mukerji G, Waters J, Chessell IP, Bountra C, Agarwal SK, Anand P, (2006a). Pain during ice water test distinguishes clinical bladder hypersensitivity from overactivity disorders. BMC Urol 6: 31.
108. Mukerji G, Yiangou Y, Agarwal SK, Anand P, (2006b). Transient receptor potential vanilloid receptor subtype 1 in painful bladder syndrome and its correlation with pain. J Urol 176: 797-801.
109. Mukerji G, Yiangou Y, Corcoran SL, Selmer IS, Smith GD, Benham CD, et al. (2006c). Cool and menthol receptor TRPM8 in human urinary bladder disorders and clinical correlations. BMC Urol 6: 6.
110. Mustafa SM, Thulesius O, (1999). Cooling-induced bladder contraction: studies on isolated detrusor muscle preparations in the rat. Urology 53: 653-657.
111. Nagata K, Duggan A, Kumar G, García-Añoveros J, (2005). Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J Neurosci 25: 4052-4061.
112. Nilius B, Voets T, (2013). The puzzle of TRPV4 channelopathies. EMBO Rep 14: 152-163.
113. Nomoto Y, Yoshida A, Ikeda S, Kamikawa Y, Harada K, Ohwatashi A, et al. (2008). Effect of menthol on detrusor smooth-muscle contraction and the micturition reflex in rats. Urology 72: 701-705.
114. Okragly AJ, Niles AL, Saban R, Schmidt D, Hoffman RL, Warner TF, et al. (1999). Elevated tryptase, nerve growth factor, neurotrophin-3 and glial cell line-derived neurotrophic factor levels in the urine of interstitial cystitis and bladder cancer patients. J Urol 161: 438-441; discussion 441-442.
115. Ost D, Van Der Aa F, de Ridder D, (2003). Intravesical ethanol 10% in saline is not an inert vehicle. Neurourol Urodyn 22: 353-355.
116. Parsons BA, Drake MJ, (2011). Handbook of Experimental Pharmacology. Springer Berlin Heidelberg: Berlin, Heidelberg.
117. Payne CK, Mosbaugh PG, Forrest JB, Evans RJ, Whitmore KE, Antoci JP, et al. (2005). Intravesical resiniferatoxin for the treatment of interstitial cystitis: a randomized, double-blind, placebo controlled trial. J Urol 173: 1590-1594.
118. Pereira LMS, Lima-Júnior RCP, Bem AXC, Teixeira CG, Grassi LS, Medeiros RP, et al. (2013). Blockade of TRPA1 with HC-030031 attenuates visceral nociception by a mechanism independent of inflammatory resident cells, nitric oxide and the opioid system. Eur J Pain 17: 223-233.
119. Proudfoot CJ, Garry EM, Cottrell DF, Rosie R, Anderson H, Robertson DC, et al. (2006). Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr Biol 16: 1591-1605.
120. Renier WO, Gabreels FJ, (1980). Evaluation of diagnosis and non-surgical therapy in 24 children with a pontine tumour. Neuropediatrics 11: 262-273.
121. Santos-Silva A, Charrua A, Cruz CD, Gharat L, Avelino A, Cruz F, (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Auton Neurosci 166: 35-38.
122. Schaeffer AJ, (1999). Activation for CNS circuits producing a neurogenic cystitis: evidence for centrally induced peripheral inflammation. J Urol 162: 282.
123. de Sèze M, Wiart L, Joseph PA, Dosque JP, Mazaux JM, Barat M, (1998). Capsaicin and neurogenic detrusor hyperreflexia: a double-blind placebo-controlled study in 20 patients with spinal cord lesions. Neurourol Urodyn 17: 513-523.
124. de Sèze M, Wiart L, Ferrière J, de Sèze MP, Joseph P, Barat M, (1999). Intravesical instillation of capsaicin in urology: a review of the literature. Eur Urol 36: 267-277.
125. Shibata Y, Ugawa S, Imura M, Kubota Y, Ueda T, Kojima Y, et al. (2011). TRPM8-expressing dorsal root ganglion neurons project dichotomizing axons to both skin and bladder in rats. Neuroreport 22: 61-67.
126. Silva C, Silva J, Ribeiro M-J, Avelino A, Cruz F, (2005). Urodynamic effect of intravesical resiniferatoxin in patients with neurogenic detrusor overactivity of spinal origin: results of a double-blind randomized placebo-controlled trial. Eur Urol 48: 650-655.
127. Silva C, Silva J, Castro H, Reis F, Dinis P, Avelino A, et al. (2007). Bladder sensory desensitization decreases urinary urgency. BMC Urol 7: 9.
128. Stein RJ, Santos S, Nagatomi J, Hayashi Y, Minnery BS, Xavier M, et al. (2004). Cool (TRPM8) and hot (TRPV1) receptors in the bladder and male genital tract. J Urol 172: 1175-1178.
129. Steurer J, Nydegger A, Held U, Brunner F, Hodler J, Porchet F, et al. (2010). Study protocol LumbSten: the lumbar spinal stenosis outcome study. BMC Musculoskelet Disord 11: 254.
130. Story GM, Peier AM, Reeve AJ, Eid SR, Mosbacher J, Hricik TR, et al. (2003). ANKTM1, a TRP-like channel expressed in nociceptive neurons, is activated by cold temperatures. Cell 112: 819-829.
131. Streng T, Axelsson HE, Hedlund P, Andersson DA, Jordt S-E, Bevan S, et al. (2008). Distribution and function of the hydrogen sulfide-sensitive TRPA1 ion channel in rat urinary bladder. Eur Urol 53: 391-399.
132. Tsukimi Y, Mizuyachi K, Yamasaki T, Niki T, Hayashi F, (2005). Cold response of the bladder in guinea pig: involvement of transient receptor potential channel, TRPM8. Urology 65: 406-410.
133. Uvin P, Boudes M, Franken J, Pinto S, (2013a). The role of TRPA1 in the bladder cooling reflex; a possible new therapeutic target. J Urol 189: e12.
134. Uvin P, Boudes M, Menigoz A, Franken J, Pinto S, Gevaert T, et al. (2013b). Chronic administration of anticholinergics in rats induces a shift from muscarinic to purinergic transmission in the bladder wall. Eur Urol 64: 502-510.
135. Vahabi B, Parsons BA, Doran O, Rhodes A, Dean S, Drake MJ, (2013). TRPM8 agonists modulate contraction of the pig urinary bladder. Can J Physiol Pharmacol 91: 503-509.
136. Van Den Eeden SK, (2003). Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 157: 1015-1022.
137. Vay L, Gu C, McNaughton PA, (2012). The thermo-TRP ion channel family: properties and therapeutic implications. Br J Pharmacol 165: 787-801.
138. Vizzard MA, (2001). Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J Chem Neuroanat 21: 125-138.
139. Vizzard MA, Erdman SL, de Groat WC, (1996). Increased expression of neuronal nitric oxide synthase in bladder afferent pathways following chronic bladder irritation. J Comp Neurol 370: 191-202.
140. Wang Z-Y, Wang P, Merriam FV, Bjorling DE, (2008). Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice. Pain 139: 158-167.
141. Watanabe T, Yokoyama T, Sasaki K, Nozaki K, Ozawa H, Kumon H, (2004). Intravesical resiniferatoxin for patients with neurogenic detrusor overactivity. Int J Urol 11: 200-205.
142. Weinhold P, Gratzke C, Streng T, Stief C, Andersson K-E, Hedlund P, (2010). TRPA1 receptor induced relaxation of the human urethra involves TRPV1 and cannabinoid receptor mediated signals, and cyclooxygenase activation. J Urol 183: 2070-2076.
143. Wiart LL, Joseph PAP, Petit HH, Dosque JPJ, de Sèze MM, Brochet BB, et al. (1998). The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results. Spinal Cord 36: 95-99.
144. Xing H, Chen M, Ling J, Tan W, Gu JG, (2007). TRPM8 mechanism of cold allodynia after chronic nerve injury. J Neurosci 27: 13680-13690.
145. Xu X, Gordon E, Lin Z, Lozinskaya IM, Chen Y, Thorneloe KS, (2009). Functional TRPV4 channels and an absence of capsaicin-evoked currents in freshly-isolated, guinea-pig urothelial cells. Channels (Austin) 3: 156-160.
146. Yamada T, Ugawa S, Ueda T, Ishida Y, Kajita K, Shimada S, (2009). Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder. J Histochem Cytochem 57: 277-287.
147. Yiangou Y, Facer P, Ford A, Brady C, Wiseman O, Fowler CJ, et al. (2001). Capsaicin receptor VR1 and ATP-gated ion channel P2X3 in human urinary bladder. BJU Int 87: 774-779.